ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Again acquired industrial biotechnology company Genomatica (Geno), combining bioprocess engineering with AI-driven molecule discovery. The deal includes Geno's computational platform, patents, and experimental data. Again plans to integrate these assets to shorten development cycles for new production pathways. Financial terms were not disclosed.
Tap to vote and see what everyone thinks.
Summary by ByteBrief